Procaps S.A

About Procaps S.A

Procaps Group is a leading provider of Contract Development and Manufacturing services in softgel advanced technologies for the global pharmaceutical and nutraceutical industry. 

With 8 manufacturing facilities across North, Central & South America, Procaps Group’s CDMO businesses, Softigel, Sofgen Pharmaceuticals, Softcaps Brazil, and Funtrition, are bringing its extensive manufacturing capabilities and product development expertise in a wide array of Softge and gummy advanced technologies, helping companies to deliver health and innovation around the globe through new products and challenging projects in novel technologies. We are an integrated Softgel CDMO, offering end-to-end solutions from development across the delivery.

Our advanced delivery technologies, including Softgel advanced technologies, our proven formulation, manufacturing and regulatory expertise, has enabled us to become an integrated CDMO (iCDMO), giving customers full-service, turnkey solutions in prescription drugs, OTC and specialized nutraceuticals. Our differentiating strengths have enabled us to move into more difficult-to-produce compounds, formulations, dosage forms, and non-traditional manufacturing processes where few competitors can follow. Our Company is infused with a strong belief in the growing need for precisely the sort of generic drugs, specialty Pharma products, and advanced delivery technologies positioned in our pipeline, so developing long-term partnerships based on these breakthrough technologies is our state of mind.

Procaps S.A Industry Content
  • CO
  • 2015
    On CPHI since
  • 4
  • 5000+
Company types
Contract Service
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
Meet us at

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
May, 7-9, 2024

Products from Procaps S.A (7)

  • Unigel™ Fixed Dose Combination Softgels

    Product Unigel™ Fixed Dose Combination Softgels

    A unique oral dosage form that allows having tablets, capsules, granules or pellets inside a single, larger soft gelatin capsule. Unigel™ is the only patented technology for fixed dose combinations which incorporate the benefits of soft gelatin capsules. Created for patients and consumers who want...
  • Chewgels - Chewable Soft Capsules

    Product Chewgels - Chewable Soft Capsules

    Discover our Chewable Softgel Platform ChewgelsTM, chewable soft capsules as a solution and line extension to existing or new products. With new ingredients, special shapes and flavors, we can offer our customers a range of formulations for different therapeutic lines. But, when thinking about consumer...
  • Funtrition™ Gummies

    Product Funtrition™ Gummies

    At Fun-trition we are focused on offering a complete experience in every bite of our delicious gummies. From Gelatin, to Plant-based technologies to guilt-free, sugar-free gummy formulations we understand that good nutrition doesn't have to be boring. At Funtritiom, we don’t just manufacture gummies, we c...
  • Versagel™ - Plant-Based Softgels

    Product Versagel™ - Plant-Based Softgels

    Vegetarian softgels are becoming increasingly competitive with animal-based gels. ​As development efforts continue, additional areas of limitation may be overcome, such as the desire to use natural colorants and high-viscosity ingredients. ​ Meet our vegetarian softgel technolog...
  • Cannabidiol (CBD) Softgels

    Product Cannabidiol (CBD) Softgels

    We offer fully assistance for development, formula optimization, and encapsulation of CBD-THC products. Soft gelatin capsules are the ideal dosage form considering both bioavailability and stability of Cannabis medicinal products. Additionally, our unique and patenteted Unigel technology offers a unique pl...
  • G-tabs - Gelatin Coated Tablets

    Product G-tabs - Gelatin Coated Tablets

    Innovative Technologies to improve Therapeutic Adherence. Meet Gtabs, Gelatin Coated Tablets technology.  Gtabs is a Technology for tablets cotaed with gelatin, one or two tonedm, considered the best way to mask unpleasant odors and flavors, prevent counterfeiting and guarantee therapy adherence. q...

    Product SOFTGELS

    At Softigel, we offer much more than traditional softgels, including everything from a single unit dosage form, to multiple delivery systems in a single dose. Softgels are an effective delivery system for oral drugs, especially those with low solubility and/or permeability (BCS Classes II, III and...

Procaps S.A Resources (45)

  • News Unlock the full potential of an integrated Softgel CDMO during CPHI North America 2023

    Sofgen Pharmaceuticals, your flexible partner for Innovation in Softgel delivery.  

    Sofgen Pharmaceuticals by Procaps Group is an integrated CDMO/CMO that offers end-to-end from development throughout delivery for prescription drugs, OTC products and specialized nutraceuticals in Softgel advanced technologies.
  • Brochure Procaps Group iCDMO

    Offering end-to-end solutions in Softgel technologies from development across delivery. Learn more about who we are.
  • News Your Flexible Partner for Innovative Softgel Delivery

    Learn how to meet the demands of a modern industry with an integrated CDMO for tailor-made advanced Softgel technologies, and discover what our expansion into North America will mean for our production capacities and growth in our latest infographic.
  • Brochure Meet Unigel, the Smart Softgel.

    Simplifying treatments. Increasing Patient Compliance. Innovating in Sustainable Products.

  • News Innovation in Drug Delivery & Portfolio Renovation with Sofgen Pharmaceuticals

    The Pharma industry is expected to reach $1.9Tn in revenue by 2027, increasing at a rate of 3-6% per year, according to IQVIA1, with some regions being driven by volume, and others by innovation. Growth in developed economies is projected to be slow, while other regions such as Latin America, Eastern Europe and parts of Asia are expected to have a strong growth. As the pharmaceutical industry continues to evolve, CDMOs will play an increasingly important role in drug development and manufacturing. 

  • Brochure Driving consumer healthcare innovation OTC Products in Chewgels Technology

    Discover innovation and brand differentiation for your OTC products with Chewable Soft capsules technology by Procaps Group: Chewgels
  • News Discover the CPHI North America Learning Labs: Part One

    Explore the series of Learning Labs at CPHI North America across several product innovation categories in which thought leaders at our exhibitors showcase their extensive expertise in all areas of the pharma supply chain, offering industry insights across drug manufacturing, outsourcing, pharma ingredients, drug delivery and packaging.
  • Brochure The Smart Softgel for Fixed dose Combinations: Unigel technology

    Unigel™️,  is a first-to-market technology designed to combine multiple API formulations in one single soft gelatin capsule, offering multi-phase therapies, improving bioavailability, reducing manufacturing costs, and achieving superior adherence to different therapies. Unigel™️ technology provides various forms for fixed-dose combinations, such as a softgel in a softgel, a tablet in a softgel, granules in a softgel, or any combination to address challenges of multiactive formulation, offering unique prescription, otc and otx products.
  • News Softigel and creating the next super pill

    As consumers become increasingly knowledgeable about the different delivery formats available, so they continue to demand more from both pharmaceutical and nutraceutical products. As a result, the race to create the next ‘super pill’ has intensified. One of the leading contenders in this race is Unigel softgel.

    Meet our vegetarian softgel technology, Versagel™️, a versatile option for the encapsulation of high viscous, semisolid or high pH fill contents. This is a platform that has been built at Procaps from different standpoints such as: Formulation, R&D, Process, Product and Experience.
  • News How Unigel innovation is transforming fixed-dose combinations

    With advances in technology transforming drug delivery systems, these are exciting times for the pharmaceutical industry. Not only are companies finding innovative ways to optimise manufacturing processes, but more importantly, new technologies are being developed that improve the lives of patients.
  • Brochure Softgel Technology

    The Softgel Capsule is a superior delivery system with wide-ranging applications. They are a solid dosage form composed of two gelatin films that contain semisolid or liquid APIs protected by an external, hermetically sealed cover. They ensure high precision dosage by achieving homogeneity of ingredients.
  • News Comparing vegetarian soft capsules for dietary supplements: How stable is Versagel?

    Highly stable and offering a long shelf life, soft gelatin (softgel) capsules have gained popularity as an alternative supplement delivery system to oils and pills. They can also help manufacturers enhance the bioavailability of active pharmaceutical ingredients (APIs).
  • Brochure Product Development Services

    A key factor in our market success is having a R&D team working continuously on the development of formulas and pharmaceutical technologies. Our experience is at your disposal. Contact us and get to know us more! 
  • News A comparative analysis of soft vegetable capsules: Taking your brands with Versagel™ to the next level

    Carol Helena Aguilar Rodríguez – Pharmaceutical Chemist, Procaps SA

    Carolina Quintero Ochoa – PhD Polymer Science and Engineering, Procaps SA

  • Brochure Softgels Gone Chewable

    Selecting the right delivery format for your next product launch is not an easy decision, essentially it should depend on several factors such as dosage, formulation, absorption, quality, but have you thought about consumer preference and experience when choosing the format for your next big launch? Which formats are today providing enjoyable and consumer experiences, being tasteful, convenient, and delivering the required nutrition consumers are looking for?
  • News The Top 5 Industry Content Reads on CPHI Online

    If you’re looking for news, product information and market trends from leading pharma companies, the Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner. 

    The Company Showcase profiles offer a library of free to access, downloadable content, including videos and webinars, reports, whitepapers and product brochures, from the Pharma suppliers and service providers you’d look to meet at our events.

  • Brochure Integrated Solutions from development to delivery in Softgel technologies

    Get to know more about our integrated manufacturing capabilities and development expertise for companies seeking an ideal partner to help them grow and innovate.
  • News Usin Near-Infrared spectroscopy and chemometric modeling to simultaneously determine ibuprofen and caffeine concentration in softgels

    Appearing in the September 2020 edition of Tablets & Capsules, this article summarizes a method for rapid and accurate determination of API concentration in the fill of soft gelatin capsules while little or no sample preparation. Applying chemometric models to near-infrared spectrum data allows scientists to predict the API content in samples from the manufacturing process and the final product.
  • Brochure Simplifying Treatments with Fixed dose combinations in Softgels

    Meet Unigel, the Smart Softgel. Proprietary technology by Procaps that allows multi-therapies in one single dose. Powerful combinations and formulations in Rx products customized to our customers´needs.
  • News Vegetarian substitues for Soft Gelatin Capsules

    The present is an overview of the state-of-the-art for vegetarian soft capsules in terms of materials (sourcing and demand), applications, processing, products and a general insight of the current state of materials and technology of these gelatin alternatives.

  • Brochure Extended manufacturing and development capabilities for proximity with our customers´and prospect partners: Sofgen Pharmaceuticals

    Sofgen Pharmaceuticals, part of Procaps Group, is an integrated Softgel CDMO that offers end-to-end solutions in Softgel technologies from development through delivery for prescription drugs, OTC products, and specialized nutraceuticals for pharmaceutical companies looking for differentiation, while simultaneously improving efficiency, and gaining access to specialized expertise, and unique technologies for their products.
  • News Driving advanced gummy solutions

    Gummy supplements alone have gained the most market share in relation to others non-pill formats doubling in size over the last five years
  • Brochure OTC Products in Chewgels Technology

    Discover innovation and brand differentiation for your OTC products with Chewable Soft capsules technology by Procaps Group: Chewgels
  • News Unigel: The Smart Softgel

    Learn more on our unigel technology, platform for multi-purpose, multi-dose therapies in fixed dose combinations in softgels. Ready-to-market formulas available. 
  • Technical Data US Softgel Facility, Sofgen Pharmaceuticals

    Get to know more about our expanded capabilities for proximity and to better serve our customers and prospect partners in their markets.
  • News Be the first in your markets with Softigel by Procaps

    Get a closer look at how our team of experts identify market opportunities from an early stage and are constantly thinking of ways to revolutionize the pharmaceutical industry:
  • Technical Data Rx Combinations in Unigel Technology

    UnigelTM is aimed for brands who want their patients to have simplicity and effectiveness without comprising quality, backed by science and technology.

    This revolutionary form provides different configurations for Rx, OTC and specialized nutraceutical products.

    UnigelTM understands consumers requirements, but also provides customers with the quality, regulatory expertise, time and cost effectiveness they deserve.

  • Technical Data Sofgen Lab Services

    Our success developing precise analythical methods and deliver unmatched quality in routine analytics gives us experience that is vital to the success of your projects. 
  • Technical Data High Potent Compound Capabilities

    Procaps counts with Deep knowledge and extensive experience in the Development and manufacturing of complex hormone therapy drugs, supported by our advanced softgel technologies. Learn more
  • Technical Data Your Global Partner in Softgel Technologies Overview

    In today’s rigid environment, being an essential partner in innovation in the pharmaceutical andnutraceutical industries means adapting and responding swiftly to the evolving landscape of medicaladvancements and market dynamics, it involves fostering a mindset that embraces change,collaboration, and agility.Procaps Group is your ideal flexible partner that fully understands the importance of staying ahead ofthe curve by actively seeking new opportunities, exploring novel technologies, anticipating emergingneeds and proximity to its customers.Throughout their different specialized facilities across North, Central & South America, ProcapsGroup’s iCDMO businesses Softigel®, Sofgen Pharmaceuticals®, Softcaps® Brazil, and Funtrition®, isable to offer extensive manufacturing capabilities, exclusive delivery systems and product developmentexpertise making them your ideal partner in softgel technologies.
  • Whitepaper Challenges and Opportunities in the development of foxed dose combinations in softgels

    This article is aimed to offer a general review of the fixed dose combinations (FDC), the manufacturing technologies and their applications, benefits and setbacks as well as a case study to illustrate the product concept based on the new technological platform of Unigel®️ for FDCs in soft gelatin capsules
  • Whitepaper Softgel Formulation & Analytical Development

    One of the most frequent issues in product development of soft gelatin capsules is dissolution performance. Gelatin is a protein containing terminal reactive amino o carboxylic groups which proceed to crosslinking reactions, leading to the formation of insoluble high molecular weight chains that decrease or limit the release of the fill content of the capsules to the dissolution media. The progress of this reaction will depend on the content of high molecular weight chains, the content of free groups to react in gelatin or the reactive impurities in excipients. In product formulation, some properties of the gelatin such as the gelatin type and the molecular weight have been identified to determine the dissolution of the product. In regards to the gelatin formulation, some relevant variables are the type and content of plasticizer.
  • Whitepaper What´s Behind Plant-Based Soft Capsules?

    The present is an overview of the state-of-the-art for vegetarian soft capsules in terms of materials (sourcing and demand), applications, processing, products and a general insight of the current state of materials and technology of these gelatin alternatives.
  • Whitepaper Advantages of Soft Gelatin Capsules Dosage Form in the Manufacture Of Cannabis-based Products

    Selecting the appropriate dosage form in the development and manufacturing of Cannabis-based products plays an important role in the success of the drug product because the dosage form selected should be able to protect the drug substance during all the shell life and facilitate its handling and administration to patients and consumers.
  • Whitepaper Challenges and opportunities for the adoption of 3D printing technologies in the Pharmaceutical Industry: An overview of additive manufacturing techniques, the case for Fixed-Dose Combinations

    Fixed-dose combinations are the preferred approach to simplify the management of chronic diseases such as HIV, asthma, diabetes, lipid regulation, and hypertension by reducing the number of dosage intake and improving efficacy as well as offering a more cost-effective therapeutic option to monotherapy. However, there are various challenges in the fabrication of multi-layered tablets that need to be considered to achieve optimal manufacturing at an industrial scale. This whitepaper from Procaps provides an overview of recent academic works regarding the implementation of how Additive Manufacturing (3D Printing) technologies have emerged to develop pharmaceutical products, particularly the design and manufacturing of dose combination products for chronic patients.
  • Video Two Worlds, One Union: Dive into the world of Unigel™ Technology

    Discover how our passion for innovation turns into revolutionary technologies that are ideal for consumers health and nutrition. Unigel™ is the only technology available for fixed dose combinations, that allows multiple ingredients to co-exist in one single dose
  • Video The future of Innovation in Pharmaceutical Delivery Systems

    Procaps is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in Latin America and, as of December 31, 2020, had more than 4,700 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions. 
  • Video Innovation As a Differentiation in Technology, Products and Culture

    More than 4 decades developing medical solutions for the world.
  • Video Making a difference through exceptional experiences for healthier lives

    At Softigel® by Procaps, we are continuously working on bringing you unique product features to differentiate your brand. Breakthrough technologies to reach new markets.  

     Through our extensive capabilities and deep expertise in product development and softgel manufacturing, we help different companies bring innovative products to their markets faster, offering their patients and consumers an exceptional experience, high preference, and superior adherence to different therapies.

  • Video Softigel, an integrated CDMO

    As an integrated CDMO in Softgel Technologies, we offer end-to-end solutions from development across delivery.We value ourselves as a business partner that can be flexible enough to work with your needs and deliver innovative and specialty products that fit your patients and market needs. Meet with us
  • Video Exploring the Promise of Latam Pharma

    This webinar originally aired as part of CPHI Discover - 17-28 May 2021 Latin America is a diverse market with a huge population that has commanded the attention of pharma companies as one to watch. This session will explore how the potential of this dynamic market can be tapped into. Overview of the current market opportunities & challenges across key markets - Brazil, Mexico, Chile, Colombia, Argentina and Central America. Key therapy areas & most promising markets Innovation landscape Potential drivers to the increasing internationalization of the LatAm Pharma Market What has been the impact of the pandemic on the Latam pharmaceutical market?
  • Video Unlocking the Power and Versatility of Plant-Based Softgels

    This webinar originally aired as part of CPHI Discover - 17-28 May 2021 While plant-based diets continue to grow in popularity, the desire to live and act more sustainably and healthfully is on the rise. With our Vegetarian Softgel Technology, Versagel™, companies can now offer their patients and consumers Non-GMO, plant-based softgel products as an optimal solution for their latest demands without losing the versatility and benefits of regular softgel capsules. Changing to a plant-based alternative should not affect overall product performance and quality. Versagel™ offers not only great appearance, but an overall competitive edge, the cornerstone for your next big project. Join us!
  • Video Flexibility & Innovation in Softgel Delivery: Sofgen Pharmaceuticals

    We are an integrated CDMO that offers end-to-end solutions, from developmentthroughout delivery, in innovative Softgel technologies for pharma andhealthcare companies interested in launching novel products within NorthAmerica and other Highly regulated markets.
  • Podcast Podcast: Are 3D printed drugs the future of personalized medicine?

    The Pharma industry is shifting from volume to value – addressing smaller patient populations and rare diseases. 3D printing (3DP) technologies have a transformational role to play. However, 3DP comprises an array of different additive manufacturing technologies of which only some can be adapted to the use in pharmaceutics. This session will discuss the use of 3D printing in a hospital setting to prepare personalised therapies for paediatric patients. For the first time, 3D printing offers a feasible, rapid and automated approach to prepare oral tailored-dose therapies for patient improving safety and adherence to the treatment. Podcast aired as part of the CPHI Festival of Pharma